FDA inspection
Zhejiang Jingxin Pharmaceutical Co., Ltd: FDA inspection ending Jun 21, 2024
FDA inspection 1243909 · No Action Indicated (NAI) · Shaoxing
Key facts
| Inspection ID | 1243909 |
|---|---|
| Firm | Zhejiang Jingxin Pharmaceutical Co., Ltd |
| FEI number | 2000033505 |
| Address | No.800, Xinchang Ave. East Rd., Yulin St., Xinchang County |
| City | Shaoxing |
| Fiscal year | 2024 |
| Inspection end date | Jun 21, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data